Last Updated: April 16, 2026 · Medically Reviewed by Dr. Robert Sullivan, MD
Pygeum Africanum is a bark extract from the African plum tree (Prunus africana). A 2002 Cochrane meta-analysis of 18 randomized controlled trials in 1,562 men found Pygeum produced significant improvements in nighttime urination (nocturia), residual urine volume, and peak urine flow — placing it among the best-documented botanicals for lower urinary tract symptoms in men.
Pygeum Africanum (Prunus africana) is a large evergreen tree native to the mountainous regions of sub-Saharan Africa — particularly Cameroon, Madagascar, and Kenya. African traditional medicine has used the bark for urinary complaints in men for centuries, and European researchers became interested in the 1960s, leading to standardized extract development in France. Pygeum has been prescribed as a regulated medication for BPH in several European countries for decades.
The bark contains a complex mixture of active compounds: phytosterols (especially beta-sitosterol), pentacyclic triterpenes (ursolic, oleanolic acid), long-chain fatty alcohols (docosanol, tetracosanol), and ferulic acid esters. Standardized extracts are typically calibrated to contain specific concentrations of beta-sitosterol and other markers to ensure batch-to-batch consistency.
Pygeum works through several interlocking mechanisms, distinct from but complementary to Saw Palmetto's 5-alpha reductase inhibition:
Anti-inflammatory action on prostate tissue: The pentacyclic triterpenes in Pygeum inhibit inflammatory signaling pathways (including 5-lipoxygenase and leukotriene production) within prostate tissue. Chronic low-grade prostate inflammation is increasingly recognized as a contributor to BPH symptoms independent of gland size itself.
Modulation of growth factor signaling: Research suggests Pygeum affects growth factors (including basic fibroblast growth factor and epidermal growth factor) involved in prostate cell proliferation. This may slow the progressive tissue expansion characteristic of BPH.
Bladder emptying improvement: Pygeum's most distinctive clinical effect — and the reason it's so often added to Saw Palmetto in formulas — is on bladder emptying. Multiple trials have documented significant reductions in residual urine volume (the amount of urine left in the bladder after urination) with Pygeum supplementation. A bladder that empties more completely means the refill cycle takes longer before the next urge — which directly translates to fewer bathroom trips.
The most comprehensive evidence base for Pygeum comes from a 2002 Cochrane systematic review (PMID 11869601). The review examined 18 randomized, placebo-controlled or comparative trials with 1,562 men and concluded that Pygeum provided "a moderately large improvement in the combined outcome of urologic symptoms and flow measures." Specific findings included:
These effect sizes are clinically meaningful — a reduction of roughly one nighttime bathroom trip per night is exactly what men with BPH most want. The research quality varies across included studies, but the consistent direction of effect across multiple trials strengthens confidence in the overall conclusion.
Nocturia — waking multiple times at night to urinate — isn't just an annoyance. Chronic nocturia systematically degrades sleep architecture, reducing time in deep slow-wave sleep and REM sleep. The downstream effects are cumulative: reduced daytime energy, declining cognitive sharpness, depressed mood, impaired immune function, and accelerated cardiovascular risk.
A large epidemiological study found men with moderate to severe nocturia (3+ nighttime trips) had measurably higher mortality rates over follow-up compared to men sleeping through the night — not because nocturia itself is deadly, but because the chronic sleep disruption erodes cardiovascular and metabolic health. Addressing nocturia is not cosmetic — it's one of the higher-leverage interventions available for aging male health.
Pygeum's specific, documented effect on nocturia makes it among the most valuable ingredients in any prostate formula. ViriFlow users repeatedly cite reduced nighttime bathroom trips as the first and most life-changing benefit they notice — reflecting what clinical research has documented.
Clinical trials have most commonly used Pygeum extract at 100–200 mg per day of a lipidosterolic extract. Products using whole bark powder rather than standardized extract deliver variable and usually lower doses of active compounds. Consistent daily use for at least 60 days is needed before evaluating efficacy; most clinical studies ran 60 days to 6 months.
Pygeum is paired with Saw Palmetto in most evidence-based prostate formulas because the two ingredients complement each other: Saw Palmetto works on the DHT pathway, Pygeum on inflammation and bladder emptying. In ViriFlow, both are included alongside seven other ingredients that address additional dimensions of the prostate/urinary problem.
Pygeum is generally very well tolerated. Clinical trials have reported side effect rates comparable to placebo, with the most common mild issues being occasional gastrointestinal upset or nausea. Unlike finasteride, Pygeum has not been associated with sexual dysfunction side effects.
Sustainability note: wild Pygeum bark harvesting has historically threatened the Prunus africana species in Africa. Reputable supplement manufacturers source Pygeum from sustainable cultivated plantations rather than wild harvesting. Consumers concerned about sustainability should look for sustainability certification or product information stating cultivated-source bark.
Pygeum appears most beneficial for men whose dominant BPH symptoms are nighttime urination and sensation of incomplete bladder emptying. These are exactly the symptoms that most reliably respond to Pygeum in clinical trials. Men whose main complaint is urine stream weakness may benefit more from Saw Palmetto's prostate-size effect — but most men have both symptoms to varying degrees and benefit from both ingredients together.
ViriFlow combines Pygeum Africanum with Saw Palmetto as the foundation prostate-support botanicals. Adding Neem provides urinary tract cleansing support. The four marine ingredients (Wakame, Kelp, Nori Yaki, Bladderwrack) bring mineral-flushing properties. Shilajit and Pomegranate add testosterone and antioxidant support. The result is a formula that addresses nocturia (Pygeum), prostate size (Saw Palmetto), inflammation (multiple ingredients), and mineral buildup (marine ingredients) simultaneously.
The liquid drop format ensures consistent daily intake without the capsule-absorption variability that can affect standardized extract bioavailability. A single morning dropper delivers the full multi-ingredient complement.
If nighttime urination is your most bothersome symptom, Pygeum is the ingredient most likely to produce direct relief. It is well-documented in independent Cochrane meta-analysis, has a solid safety profile, and has been used clinically in Europe for decades. In a combination formula like ViriFlow, Pygeum works alongside Saw Palmetto and other compounds to address multiple dimensions of prostate and urinary health simultaneously. Commit to at least 60 days of consistent daily use before evaluating results — the effect builds gradually as inflammation and bladder function improve.
